|
2017-01-10 |
2017-01-09 |
PS
Planned sale
|
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
|
32,000
-19.8%
23.78
USD 760,960
|
32,000
-19.8%
|
23.78
|
USD 760,960
|
|
|
2016-10-25 |
2016-10-24 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
19,638
-9.0%
9.56
USD 187,739
|
19,638
-9.0%
|
9.56
|
USD 187,739
|
|
|
2016-10-05 |
2016-10-03 |
PS
Planned sale
|
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Officer
|
47,384
-26.8%
13.46
USD 637,812
|
47,384
-26.8%
|
13.46
|
USD 637,812
|
|
|
2016-09-28 |
2016-09-28 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
8,750
-3.9%
13.98
USD 122,311
|
8,750
-3.9%
|
13.98
|
USD 122,311
|
|
|
2016-09-23 |
2016-09-22 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
20,000
-8.7%
13.43
USD 268,536
|
20,000
-8.7%
|
13.43
|
USD 268,536
|
|
|
2016-09-16 |
2016-09-15 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
59,369
-20.6%
11.73
USD 696,398
|
59,369
-20.6%
|
11.73
|
USD 696,398
|
|
|
2016-08-23 |
2016-08-22 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
19,436
-7.8%
10.47
USD 203,538
|
19,436
-7.8%
|
10.47
|
USD 203,538
|
|
|
2016-08-15 |
2016-08-12 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
25,000
-9.2%
10.50
USD 262,500
|
25,000
-9.2%
|
10.50
|
USD 262,500
|
|
|
2016-07-25 |
2016-07-22 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
18,286
-6.9%
8.11
USD 148,230
|
18,286
-6.9%
|
8.11
|
USD 148,230
|
|
|
2016-07-05 |
2016-07-01 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
30,000
-10.1%
7.48
USD 224,481
|
30,000
-10.1%
|
7.48
|
USD 224,481
|
|
|
2016-07-05 |
2016-07-01 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
31,422
-10.5%
7.48
USD 235,153
|
31,422
-10.5%
|
7.48
|
USD 235,153
|
|
|
2016-06-29 |
2016-06-28 |
S
Sale
|
Cole Hugh M
SVP, Chief Business Officer
Officer
|
6,012
-16.7%
7.05
USD 42,385
|
6,012
-16.7%
|
7.05
|
USD 42,385
|
|
|
2016-06-23 |
2016-06-22 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
23,999
-8.3%
7.28
USD 174,638
|
23,999
-8.3%
|
7.28
|
USD 174,638
|
|
|
2016-06-15 |
2016-06-15 |
S
Sale
|
LAVIDAS ATHANESE
Non-Executive Director
|
46,250
-26.0%
8.24
USD 381,137
|
46,250
-26.0%
|
8.24
|
USD 381,137
|
|
|
2016-06-15 |
2016-06-14 |
S
Sale
|
LAVIDAS ATHANESE
Non-Executive Director
|
20,000
-13.2%
8.14
USD 162,852
|
20,000
-13.2%
|
8.14
|
USD 162,852
|
|
|
2016-06-14 |
2016-06-14 |
S
Sale
|
Radaelli Massimo
Non-Executive Director
|
6,250
-5.6%
8.13
USD 50,834
|
6,250
-5.6%
|
8.13
|
USD 50,834
|
|
|
2016-06-15 |
2016-06-13 |
S
Sale
|
LAVIDAS ATHANESE
Non-Executive Director
|
10,000
-7.1%
8.21
USD 82,050
|
10,000
-7.1%
|
8.21
|
USD 82,050
|
|
|
2016-06-14 |
2016-06-13 |
S
Sale
|
Radaelli Massimo
Non-Executive Director
|
79,731
-43.0%
8.25
USD 657,821
|
79,731
-43.0%
|
8.25
|
USD 657,821
|
|
|
2016-06-14 |
2016-06-10 |
S
Sale
|
Radaelli Massimo
Non-Executive Director
|
22,588
-17.6%
8.30
USD 187,480
|
22,588
-17.6%
|
8.30
|
USD 187,480
|
|
|
2016-05-25 |
2016-05-23 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
17,762
-5.8%
8.08
USD 143,430
|
17,762
-5.8%
|
8.08
|
USD 143,430
|
|
|
2016-05-13 |
2016-05-12 |
B
Purchase
|
Panayiotopoulos Paris
President and CEO
Executive Director
|
26,990
+44.2%
7.41
USD 199,996
|
26,990
+44.2%
|
7.41
|
USD 199,996
|
|
|
2016-05-02 |
2016-05-02 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
11,700
-3.7%
7.13
USD 83,478
|
11,700
-3.7%
|
7.13
|
USD 83,478
|
|
|
2016-04-25 |
2016-04-22 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
21,409
-6.8%
7.37
USD 157,864
|
21,409
-6.8%
|
7.37
|
USD 157,864
|
|
|
2016-03-23 |
2016-03-22 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
23,834
-7.0%
6.58
USD 156,871
|
23,834
-7.0%
|
6.58
|
USD 156,871
|
|
|
2016-03-22 |
2016-03-21 |
PS
Planned sale
|
Haluska Frank
SVP, Clinical R&D, CMO
Officer
|
3,575
-2.4%
6.47
USD 23,116
|
3,575
-2.4%
|
6.47
|
USD 23,116
|
|
|
2016-03-22 |
2016-03-21 |
PS
Planned sale
|
FITZGERALD EDWARD M
Executive VP
Officer
|
5,417
-1.7%
6.47
USD 35,037
|
5,417
-1.7%
|
6.47
|
USD 35,037
|
|
|
2016-03-22 |
2016-03-21 |
PS
Planned sale
|
BERSTEIN DAVID L
SVP, Chief IP Counsel
Officer
|
2,375
-0.9%
6.47
USD 15,356
|
2,375
-0.9%
|
6.47
|
USD 15,356
|
|
|
2016-03-22 |
2016-03-21 |
PS
Planned sale
|
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Officer
|
4,000
-2.5%
6.47
USD 25,871
|
4,000
-2.5%
|
6.47
|
USD 25,871
|
|
|
2016-03-22 |
2016-03-19 |
PS
Planned sale
|
Duvall Martin J
EVP, CCO
Officer
|
4,000
-4.1%
6.47
USD 25,867
|
4,000
-4.1%
|
6.47
|
USD 25,867
|
|
|
2016-03-22 |
2016-03-19 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
5,417
-1.6%
6.47
USD 35,039
|
5,417
-1.6%
|
6.47
|
USD 35,039
|
|
|
2016-03-22 |
2016-03-19 |
PS
Planned sale
|
Cantor Maria E
SVP, Corporate Affairs
Officer
|
3,575
-2.6%
6.46
USD 23,102
|
3,575
-2.6%
|
6.46
|
USD 23,102
|
|
|
2016-03-03 |
2016-03-03 |
PS
Planned sale
|
Duvall Martin J
EVP, CCO
Officer
|
9,625
-9.8%
6.12
USD 58,863
|
9,625
-9.8%
|
6.12
|
USD 58,863
|
|
|
2016-03-03 |
2016-03-03 |
PS
Planned sale
|
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Officer
|
9,625
-6.0%
6.11
USD 58,852
|
9,625
-6.0%
|
6.11
|
USD 58,852
|
|
|
2016-03-03 |
2016-03-03 |
PS
Planned sale
|
Cantor Maria E
SVP, Corporate Affairs
Officer
|
9,625
-6.8%
6.12
USD 58,869
|
9,625
-6.8%
|
6.12
|
USD 58,869
|
|
|
2016-03-03 |
2016-03-03 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
9,625
-2.8%
6.12
USD 58,867
|
9,625
-2.8%
|
6.12
|
USD 58,867
|
|
|
2016-03-03 |
2016-03-03 |
PS
Planned sale
|
FITZGERALD EDWARD M
Executive VP, CFO
Officer
|
9,625
-3.0%
6.12
USD 58,866
|
9,625
-3.0%
|
6.12
|
USD 58,866
|
|
|
2016-03-03 |
2016-03-03 |
PS
Planned sale
|
Haluska Frank
SVP, Clinical R&D, CMO
Officer
|
10,588
-6.8%
6.11
USD 64,733
|
10,588
-6.8%
|
6.11
|
USD 64,733
|
|
|
2016-03-03 |
2016-03-03 |
PS
Planned sale
|
BERSTEIN DAVID L
SVP, Chief IP Counsel
Officer
|
9,625
-3.6%
6.12
USD 58,887
|
9,625
-3.6%
|
6.12
|
USD 58,887
|
|
|
2016-03-03 |
2016-03-02 |
S
Sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
25,047
-6.8%
6.00
USD 150,282
|
25,047
-6.8%
|
6.00
|
USD 150,282
|
|
|
2016-02-03 |
2016-02-01 |
PS
Planned sale
|
Haluska Frank
SVP, Clinical R&D, CMO
Officer
|
16,133
-10.6%
4.81
USD 77,587
|
16,133
-10.6%
|
4.81
|
USD 77,587
|
|
|
2016-02-03 |
2016-02-01 |
PS
Planned sale
|
Cantor Maria E
SVP, Corporate Affairs
Officer
|
14,667
-10.6%
4.81
USD 70,517
|
14,667
-10.6%
|
4.81
|
USD 70,517
|
|
|
2016-02-03 |
2016-02-01 |
PS
Planned sale
|
Cantor Maria E
SVP, Corporate Affairs
Officer
|
1,466
-1.1%
4.93
USD 7,227
|
1,466
-1.1%
|
4.93
|
USD 7,227
|
|
|
2016-02-03 |
2016-02-01 |
PS
Planned sale
|
Duvall Martin J
EVP, CCO
Officer
|
14,667
-15.6%
4.81
USD 70,578
|
14,667
-15.6%
|
4.81
|
USD 70,578
|
|
|
2016-02-03 |
2016-02-01 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
14,667
-4.0%
4.81
USD 70,517
|
14,667
-4.0%
|
4.81
|
USD 70,517
|
|
|
2016-02-03 |
2016-02-01 |
PS
Planned sale
|
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Officer
|
14,667
-9.4%
4.81
USD 70,548
|
14,667
-9.4%
|
4.81
|
USD 70,548
|
|
|
2016-02-03 |
2016-02-01 |
PS
Planned sale
|
BERSTEIN DAVID L
SVP, Chief IP Counsel
Officer
|
14,667
-5.5%
4.81
USD 70,515
|
14,667
-5.5%
|
4.81
|
USD 70,515
|
|
|
2016-02-03 |
2016-02-01 |
PS
Planned sale
|
FITZGERALD EDWARD M
Executive VP, CFO
Officer
|
14,667
-4.6%
4.81
USD 70,515
|
14,667
-4.6%
|
4.81
|
USD 70,515
|
|
|
2016-02-03 |
2016-02-01 |
B
Purchase
|
Panayiotopoulos Paris
President and CEO
Executive Director
|
61,099
+inf%
4.91
USD 299,996
|
61,099
+inf%
|
4.91
|
USD 299,996
|
|
|
2015-09-28 |
2015-09-28 |
PS
Planned sale
|
Cantor Maria E
SVP, Corporate Affairs
Officer
|
5,000
-4.4%
6.47
USD 32,327
|
5,000
-4.4%
|
6.47
|
USD 32,327
|
|
|
2015-09-28 |
2015-09-28 |
PS
Planned sale
|
FITZGERALD EDWARD M
Executive VP, CFO
Officer
|
8,750
-2.9%
6.46
USD 56,551
|
8,750
-2.9%
|
6.46
|
USD 56,551
|
|
|
2015-09-28 |
2015-09-28 |
PS
Planned sale
|
BERSTEIN DAVID L
SVP, Chief IP Counsel
Officer
|
5,000
-2.0%
6.46
USD 32,316
|
5,000
-2.0%
|
6.46
|
USD 32,316
|
|
|
2015-09-28 |
2015-09-28 |
PS
Planned sale
|
Duvall Martin J
EVP, CCO
Officer
|
5,000
-7.2%
6.46
USD 32,317
|
5,000
-7.2%
|
6.46
|
USD 32,317
|
|
|
2015-09-28 |
2015-09-28 |
S
Sale
|
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Officer
|
5,000
-3.8%
6.46
USD 32,316
|
5,000
-3.8%
|
6.46
|
USD 32,316
|
|
|
2015-09-28 |
2015-09-28 |
PS
Planned sale
|
Haluska Frank
SVP, Clinical R&D, CMO
Officer
|
5,500
-4.3%
6.46
USD 35,503
|
5,500
-4.3%
|
6.46
|
USD 35,503
|
|
|
2015-09-28 |
2015-09-28 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
8,750
-2.6%
6.46
USD 56,560
|
8,750
-2.6%
|
6.46
|
USD 56,560
|
|
|
2015-07-16 |
2015-07-16 |
PS
Planned sale
|
Haluska Frank
SVP, Clinical R&D, CMO
Officer
|
4,400
-3.6%
8.54
USD 37,575
|
4,400
-3.6%
|
8.54
|
USD 37,575
|
|
|
2015-07-16 |
2015-07-16 |
PS
Planned sale
|
Duvall Martin J
EVP, CCO
Officer
|
1,400
-2.3%
8.54
USD 11,956
|
1,400
-2.3%
|
8.54
|
USD 11,956
|
|
|
2015-07-16 |
2015-07-16 |
PS
Planned sale
|
FITZGERALD EDWARD M
Executive VP, CFO
Officer
|
7,000
-2.2%
8.54
USD 59,793
|
7,000
-2.2%
|
8.54
|
USD 59,793
|
|
|
2015-07-16 |
2015-07-16 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
7,000
-2.1%
8.54
USD 59,797
|
7,000
-2.1%
|
8.54
|
USD 59,797
|
|
|
2015-07-16 |
2015-07-16 |
PS
Planned sale
|
Cantor Maria E
SVP, Corporate Affairs
Officer
|
4,000
-3.5%
8.54
USD 34,162
|
4,000
-3.5%
|
8.54
|
USD 34,162
|
|
|
2015-07-16 |
2015-07-16 |
PS
Planned sale
|
BERSTEIN DAVID L
SVP, Chief IP Counsel
Officer
|
4,000
-1.7%
8.54
USD 34,162
|
4,000
-1.7%
|
8.54
|
USD 34,162
|
|
|
2015-07-16 |
2015-07-16 |
PS
Planned sale
|
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Officer
|
4,000
-3.2%
8.54
USD 34,164
|
4,000
-3.2%
|
8.54
|
USD 34,164
|
|
|
2015-05-04 |
2015-05-01 |
PS
Planned sale
|
FITZGERALD EDWARD M
Executive VP, CFO
Officer
|
60,000
-16.4%
8.80
USD 528,000
|
60,000
-16.4%
|
8.80
|
USD 528,000
|
|
|
2015-03-23 |
2015-03-23 |
PS
Planned sale
|
BERSTEIN DAVID L
SVP, Chief IP Counsel
Officer
|
2,000
-1.2%
8.56
USD 17,118
|
2,000
-1.2%
|
8.56
|
USD 17,118
|
|
|
2015-03-23 |
2015-03-23 |
PS
Planned sale
|
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Officer
|
3,000
-2.5%
8.55
USD 25,661
|
3,000
-2.5%
|
8.55
|
USD 25,661
|
|
|
2015-03-23 |
2015-03-23 |
PS
Planned sale
|
FITZGERALD EDWARD M
Executive VP, CFO
Officer
|
4,167
-1.3%
8.55
USD 35,630
|
4,167
-1.3%
|
8.55
|
USD 35,630
|
|
|
2015-03-23 |
2015-03-23 |
PS
Planned sale
|
Duvall Martin J
EVP, CCO
Officer
|
834
-1.5%
8.57
USD 7,145
|
834
-1.5%
|
8.57
|
USD 7,145
|
|
|
2015-03-23 |
2015-03-23 |
PS
Planned sale
|
Haluska Frank
SVP, Clinical R&D, CMO
Officer
|
3,300
-2.8%
8.55
USD 28,229
|
3,300
-2.8%
|
8.55
|
USD 28,229
|
|
|
2015-03-23 |
2015-03-23 |
PS
Planned sale
|
Cantor Maria E
SVP, Corporate Affairs and HR
Officer
|
4,033
-3.7%
8.55
USD 34,491
|
4,033
-3.7%
|
8.55
|
USD 34,491
|
|
|
2015-03-23 |
2015-03-23 |
PS
Planned sale
|
CLACKSON TIMOTHY P
President, R&D, CSO
Officer
|
6,667
-1.5%
8.55
USD 57,016
|
6,667
-1.5%
|
8.55
|
USD 57,016
|
|
|
2015-03-23 |
2015-03-20 |
PS
Planned sale
|
BERSTEIN DAVID L
SVP, Chief IP Counsel
Officer
|
2,375
-1.5%
8.85
USD 21,026
|
2,375
-1.5%
|
8.85
|
USD 21,026
|
|
|
2015-03-23 |
2015-03-20 |
PS
Planned sale
|
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Officer
|
4,000
-3.4%
8.85
USD 35,390
|
4,000
-3.4%
|
8.85
|
USD 35,390
|
|
|
2015-03-23 |
2015-03-20 |
PS
Planned sale
|
FITZGERALD EDWARD M
Executive VP, CFO
Officer
|
5,417
-1.8%
8.84
USD 47,908
|
5,417
-1.8%
|
8.84
|
USD 47,908
|
|
|
2015-03-23 |
2015-03-20 |
PS
Planned sale
|
Duvall Martin J
EVP, CCO
Officer
|
4,000
-6.9%
8.85
USD 35,381
|
4,000
-6.9%
|
8.85
|
USD 35,381
|
|
|
2015-03-23 |
2015-03-20 |
PS
Planned sale
|
Haluska Frank
SVP, Clinical R&D, CMO
Officer
|
3,575
-3.1%
8.85
USD 31,634
|
3,575
-3.1%
|
8.85
|
USD 31,634
|
|
